Best Fit Profiles
- research-oriented longevity protocols
Cellular metabolism and healthy aging pathways
Calcium Alpha-Ketoglutarate (Ca-AKG)
Human evidence is still early and exploratory, with stronger support currently from mechanistic and preclinical aging models.
Evidence Level C
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Early translational signal; clinical effect size uncertain
- Safety
- Moderate Risk
Human clinical endpoint evidence remains early and should be interpreted conservatively.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 1-3 g
- Timing
- Daily with meals
- Protocol Duration in Studies
- 8-24 weeks in exploratory protocols
Use is best framed as experimental while higher-quality human data mature.